IS6238A - And-þátta VIII hvötunaralló-mótefni - Google Patents

And-þátta VIII hvötunaralló-mótefni

Info

Publication number
IS6238A
IS6238A IS6238A IS6238A IS6238A IS 6238 A IS6238 A IS 6238A IS 6238 A IS6238 A IS 6238A IS 6238 A IS6238 A IS 6238A IS 6238 A IS6238 A IS 6238A
Authority
IS
Iceland
Prior art keywords
factor viii
viii catalytic
allo
antibodies
allo antibodies
Prior art date
Application number
IS6238A
Other languages
English (en)
Inventor
Kaveri Srinivas
Lacroix-Desmazes Sébastien
Kazatchkine Michel
Original Assignee
Institut National de la Santé et de la Recherche Medicale (INSERM)
Bayer Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Santé et de la Recherche Medicale (INSERM), Bayer Pharma filed Critical Institut National de la Santé et de la Recherche Medicale (INSERM)
Publication of IS6238A publication Critical patent/IS6238A/is

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IS6238A 1999-07-21 2002-01-16 And-þátta VIII hvötunaralló-mótefni IS6238A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99401841A EP1074842A1 (en) 1999-07-21 1999-07-21 Catalytic anti-factor VIII allo-antibodies
PCT/EP2000/006870 WO2001007918A1 (en) 1999-07-21 2000-07-18 Catalytic anti-factor viii allo-antibodies

Publications (1)

Publication Number Publication Date
IS6238A true IS6238A (is) 2002-01-16

Family

ID=8242069

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6238A IS6238A (is) 1999-07-21 2002-01-16 And-þátta VIII hvötunaralló-mótefni

Country Status (24)

Country Link
US (2) US7507540B1 (is)
EP (2) EP1074842A1 (is)
JP (2) JP2003505434A (is)
KR (1) KR100788435B1 (is)
CN (1) CN1229646C (is)
AU (1) AU777615B2 (is)
BR (1) BR0012613A (is)
CA (1) CA2379818A1 (is)
CZ (1) CZ2002248A3 (is)
EE (1) EE200200034A (is)
HK (1) HK1044372A1 (is)
HU (1) HUP0201941A3 (is)
IL (1) IL147700A0 (is)
IS (1) IS6238A (is)
MX (1) MXPA02000752A (is)
NO (1) NO20020253L (is)
NZ (1) NZ516702A (is)
PL (1) PL353739A1 (is)
RU (1) RU2258935C2 (is)
SK (1) SK862002A3 (is)
TR (1) TR200200340T2 (is)
UA (1) UA75867C2 (is)
WO (1) WO2001007918A1 (is)
ZA (1) ZA200200351B (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101398290B1 (ko) 2010-11-17 2014-05-22 추가이 세이야쿠 가부시키가이샤 혈액응고 제viii 인자의 기능을 대체하는 기능을 갖는 다중특이성 항원 결합 분자
FR2969761A1 (fr) * 2010-12-22 2012-06-29 Lfb Biotechnologies Procede de dosage d'anticorps diriges contre le facteur viii
TWI701435B (zh) 2014-09-26 2020-08-11 日商中外製藥股份有限公司 測定ｆｖｉｉｉ的反應性之方法
TWI700300B (zh) 2014-09-26 2020-08-01 日商中外製藥股份有限公司 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體
CR20180554A (es) 2016-04-28 2019-01-10 Chugai Pharmaceutical Co Ltd Preparaciones que contienen anticuerpos
CN119161488A (zh) 2017-11-01 2024-12-20 中外制药株式会社 具有降低的生物活性的抗体变体和同种型

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744446A (en) * 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
AU5602394A (en) * 1992-11-13 1994-06-08 Duke University Chimeric blood coagulation proteins
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
US5744326A (en) * 1996-03-11 1998-04-28 The Immune Response Corporation Use of viral CIS-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites

Also Published As

Publication number Publication date
CN1229646C (zh) 2005-11-30
EP1196782A1 (en) 2002-04-17
BR0012613A (pt) 2002-04-09
CA2379818A1 (en) 2001-02-01
HUP0201941A2 (en) 2002-10-28
JP2009292823A (ja) 2009-12-17
EP1074842A1 (en) 2001-02-07
JP2003505434A (ja) 2003-02-12
HK1044372A1 (zh) 2002-10-18
HUP0201941A3 (en) 2005-01-28
CN1361865A (zh) 2002-07-31
AU6824500A (en) 2001-02-13
ZA200200351B (en) 2003-03-26
NO20020253D0 (no) 2002-01-17
US20090208512A1 (en) 2009-08-20
WO2001007918A1 (en) 2001-02-01
KR20020042618A (ko) 2002-06-05
KR100788435B1 (ko) 2007-12-24
UA75867C2 (en) 2006-06-15
EE200200034A (et) 2003-06-16
SK862002A3 (en) 2002-06-04
IL147700A0 (en) 2002-08-14
NZ516702A (en) 2003-10-31
TR200200340T2 (tr) 2003-01-21
PL353739A1 (en) 2003-12-01
RU2258935C2 (ru) 2005-08-20
NO20020253L (no) 2002-03-13
US7507540B1 (en) 2009-03-24
MXPA02000752A (es) 2003-07-14
CZ2002248A3 (cs) 2002-07-17
AU777615B2 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
NO2022060I1 (no) Aflibercept
ID28627A (id) Katalis
NL300939I2 (nl) Benralizumab
NO20014238L (no) Spesifikasjon for ABAP-kode konverter
NO20022615D0 (no) Koboltkatalysatorer
DE60030340D1 (de) Kraftfahrzeugstruktur
NO20023320D0 (no) Katalytisk reaktor
DE69902548D1 (de) Katalysatoraktivatorverbindung
DE60012103D1 (de) Fahrzeugbaustruktur
DE10197023T1 (de) Fischer-Tropsch-Katalysatoren
DE60015683D1 (de) Fahrzeugbaustruktur
DE60025098D1 (de) Fahrzeugbaustruktur
NO981126D0 (no) Forbedret katalysatorbærer
DE60002566D1 (de) Katalysatorsysteme
ID29169A (id) Penguatan rangka kendaraan
ID26688A (id) Katalis-katalis unggun tetap
NO20021020D0 (no) Kjöretöy
NO20003934D0 (no) Oksydkatalysatorer
DE50009579D1 (de) Kraftfahrzeug-Türschliesssystem
DE60003901D1 (de) Fahrzeug
ITMI991348A0 (it) Procedimento migliorato di fischer-tropsch
DE60014260D1 (de) Klammer
NO20020253L (no) Katalytiske anti-faktor VIII allo-antistoffer
DE60142845D1 (de) Katalysatorträger
DE60041737D1 (de) Fahrzeug